Displaying items by tag: oneal comprehensive cancer center

Physicians in the O’Neal Comprehensive Cancer Center at UAB are advancing the field of thyroid care with cutting-edge, patient-specific procedures and collaborative research investigations.
UAB’s CAR T-cell therapy cured stage 4 lymphoma with the help of the patient’s resilience and the doctor’s timely diagnosis and treatment.
This grant will promote digital health literacy to assist with the growing need of patient engagement with technology.
As the Minority Health & Health Equity Research Center embarks on its next phase, it calls on all community members to work together to make health equity a reality.
UAB researchers have discovered a new way to treat melanoma by targeting CDC7 with EZH2 or BRPF1/2/3 inhibitors.
Lung cancer patients in rural Alabama now have access to first-in-class stereotactic radiation treatments performed by UAB Medicine physicians.
Anthony Natale shares his unforgettable experience with the Proton International staff and joy for being its 500th patient. 
The deciphering of a new signaling cascade sheds light on how mutations in metabolism cause normal cells to become cancerous.
The researchers found that ARID1A-deficient bladder cancers are sensitive to combination therapies with the EZH2 inhibitor and inhibitors of PI3K, in a synergistic manner.
At UAB, undergraduate students with a passion for medicine have the option to receive a specialized degree in cancer biology — a degree found nowhere else in the country.
All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival.
Page 1 of 30